AI Science Tracker
EN

Yunnan University of Chinese Medicine

1 discovery from 2026

Discoveries

Phenylpropanoid Amides from Buteae monospermae Semen as Hepcidin-Modulating Candidates for Anemia of Inflammation: Network Pharmacology, Deep Learning Prediction, and In Vitro Validation

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Deep-learning affinity prediction helped prioritize two Butea monosperma compounds for follow-up. In IL-6-stimulated HepG2 cells, both dose-dependently reduced hepcidin; this is an in vitro candidate result, not evidence of treatment efficacy.

Technology: Deep-learning affinity prediction with network pharmacology and in vitro assays

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Deep-learning affinity prediction ranked candidate targets for Butea compounds, alongside network pharmacology, docking and molecular dynamics; the cell assay tested the prioritized candidates.
Limitation / still unknown
The study evaluates the reported models and datasets only; broader generalization and real-world deployment outcomes were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://mdpi-res.com/d_attachment/molecules/molecules-31-04031/article_deploy/molecules-31-04031.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.